Participants:18–64 years · 65+ years
Substances:Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker

Contact Research Centre

Pleural mesothelioma

Recruiting

Registered drugNo placebo

Study of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Renal cell carcinoma

Recruiting

Registered drugNo placebo

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Breast cancer+2

Recruiting

InvestigationalNo placebo

A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Datopotamab Deruxtecan

Contact Research Centre

Asthma

Recruiting

Investigational

Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

Investigational

France

Participants:18–64 years · 65+ years
Substances:HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST TSLP

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Testing sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Sacituzumab Govitecan

Contact Research Centre

Non-small cell lung cancer stage IV+2

Recruiting

Registered drug

A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hereditary angioedema

Recruiting

Investigational

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Investigational

France

Participants:18–64 years · 65+ years
Substances:ADX-324

Contact Research Centre

Comparing Ursodeoxycholic Acid and Prednisone for Treating Liver Inflammation Caused by Cancer Immunotherapy in Adult Patients

Recruiting

Registered drugNo placebo

Comparing Ursodeoxycholic Acid and Prednisone for Treating Liver Inflammation Caused by Cancer Immunotherapy in Adult Patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Central nervous system lymphoma

Recruiting

Registered drugNo placebo

Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Anaemia

Recruiting

Registered drugNo placebo

Study of luspatercept for patients with rare inherited anemias to reduce transfusion needs and improve hemoglobin levels

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Find therapies in clinical trials near you – page 12

1 090 trials match your criteria

Prostate cancer

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Facioscapulohumeral muscular dystrophy

A Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy

Pleural mesothelioma

Study of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment

Renal cell carcinoma

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Breast cancer+2

A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

Asthma

Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

Triple negative breast cancer

Testing sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer

Non-small cell lung cancer stage IV+2

A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment

Hereditary angioedema

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Comparing Ursodeoxycholic Acid and Prednisone for Treating Liver Inflammation Caused by Cancer Immunotherapy in Adult Patients

Comparing Ursodeoxycholic Acid and Prednisone for Treating Liver Inflammation Caused by Cancer Immunotherapy in Adult Patients

Central nervous system lymphoma

Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

Anaemia

Study of luspatercept for patients with rare inherited anemias to reduce transfusion needs and improve hemoglobin levels

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.